2DS-14035-97067 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Dose 1 — Pfizer-BioNTech
2021-03-24
Registered in v-safe
2021-03-24
Dose 2 — Pfizer-BioNTech
2021-03-24
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-03-30
Survey response — days 1–6 daily, dose 2
MedDRA: Epistaxis — Feeling: Fair

Free text: Nose bleed

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-31
Survey response — day 7, dose 2
MedDRA: Nasal congestion — Feeling: Fair

Free text: Nasal congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Survey response — day 14, dose 2
MedDRA: Epistaxis — Feeling: Good

Free text: Nose bleeds

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-21
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-06
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-25
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-21
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-02-20
Survey response — 3 months, dose 3
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Covid-19

MedDRA releases: 2024-11 · check-in free text available
2022-02-20
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-25
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-05-24
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-11-21
Survey response — 12 months, dose 3
MedDRA: Arthropathy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Joint issues

MedDRA releases: 2024-11 · check-in free text available
2022-11-21
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-22
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Pfizer-BioNTech
2	2021-03-24	Pfizer-BioNTech
3	2021-11-21	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-02-20	Successful 2022-02-25	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-11-21	Successful 2022-11-22	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-30

Systemic reaction (other): Nose bleed

Release 6 — day 7, dose 2

2021-03-31

Systemic reaction (other): Nasal congestion

Release 7 — day 14, dose 2

2021-04-07

Symptoms: Nose bleeds

Release 11 — 3 months, dose 3

2022-02-20

Symptoms: Covid-19

Release 12 — 12 months, dose 3

2022-11-21

Symptoms: Joint issues

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthropathy	·	·	✓
SD	COVID-19	·	·	✓
SD	Epistaxis	✓	✓	✓
SRO	Epistaxis	✓	✓	✓
SRO	Nasal congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release